Ignite Creation Date:
2024-05-06 @ 4:07 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04873570
Status:
COMPLETED
Last Update Posted:
2022-09-07
First Post:
2021-04-28
Brief Title:
Bioequivalence Study of Mofest 400mg Moxifloxacin Tablet With Avelox 400mg Moxifloxacin Tablet in Healthy Pakistani Subjects
Sponsor:
University of Karachi
Organization:
University of Karachi
Study Overview
Official Title:
A Single Center Open Label Randomized Single-dose Two-period Two-way Cross-over Study to Compare the Rate and Extent of Absorption of Mofest 400mg Moxifloxacin Tablet With Avelox 400mg Moxifloxacin Tablet in Healthy Pakistani Subjects
Status:
COMPLETED
Status Verified Date:
2022-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BE
Brief Summary:
Single oral dose of test and reference Tablet will be administered to healthy volunteers after at least 10 hours fast together with 240 mL of ambient temperature water at their scheduled dosing time-points Blood samples will be taken up to 720 hours post-dose
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None